NORDEN GROUP LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1990699 PROVO, UT

Position in HALO

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$724,780

+$102,523 QoQ

Shares Held

9,260

-3.8% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#340

of 664 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORDEN GROUP LLC holds $6,505,916 across 12 Biotechnology names. HALO ranks #3 (11.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,542	$1,759,417
2	REGN	Regeneron Pharmaceuticals, Inc.	1,645	$1,025,723
3	HALO	Halozyme Therapeutics, Inc. This page	9,260	$724,780
4	LGND	Ligand Pharmaceuticals Inc	1,783	$563,588
5	ALNY	Alnylam Pharmaceuticals, Inc.	1,792	$539,445
6	TGTX	Tg Therapeutics, Inc.	7,461	$409,907
7	PTGX	Protagonist Therapeutics, Inc	2,868	$351,559
8	TECH	BIO-TECHNE Corp	3,884	$274,404

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$724,780	9,260	-3.8%	Shares	Sole	2026-07-29
2026-03-31	$622,257	9,628	-17.6%	Shares	Sole	2026-04-15
2025-12-31	$786,737	11,690	-4.5%	Shares	Sole	2026-01-13
2025-09-30	$897,681	12,240	-23.3%	Shares	Sole	2025-10-15
2025-06-30	$830,291	15,961	-17.8%	Shares	Sole	2025-07-15
2025-03-31	$1,239,062	19,418	-30.7%	Shares	Sole	2025-05-07
2024-12-31	$1,338,727	28,001	-1.8%	Shares	Sole	2025-02-05
2024-09-30	$1,632,313	28,517	+72.1%	Shares	Sole	2024-10-17
2024-06-30	$867,762	16,573	+29.3%	Shares	Sole	2024-08-06
2024-03-31	$521,354	12,816	+46.9%	Shares	Sole	2024-04-30
2023-12-31	$322,476	8,725	+54.8%	Shares	Sole	2024-02-05
2023-09-30	$215,257	5,635	—	Shares	Other	2023-11-06
No filing history on record for this holder in this stock.